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The neural circuits involved in mediating complex behaviors are being rapidly elucidated
using various newly developed and powerful anatomical and molecular techniques,
providing insights into the neural basis for anxiety disorders, depression, addiction, and
dysfunctional social behaviors. Many of these behaviors and associated physiological
processes involve the activation of the amygdala in conjunction with cortical and
hippocampal circuits. Ascending subcortical projections provide modulatory inputs
to the extended amygdala and its related nodes (or “hubs”) within these key circuits.
One such input arises from the nucleus incertus (NI) in the tegmentum, which sends
amino acid- and peptide-containing projections throughout the forebrain. Notably,
a distinct population of GABAergic NI neurons expresses the highly-conserved
neuropeptide, relaxin-3, and relaxin-3 signaling has been implicated in the modulation
of reward/motivation and anxiety- and depressive-like behaviors in rodents via actions
within the extended amygdala. Thus, a detailed description of the relaxin-3 innervation
of the extended amygdala would provide an anatomical framework for an improved
understanding of NI and relaxin-3 modulation of these and other specific amygdala-
related functions. Therefore, in this study, we examined the distribution of NI projections
and relaxin-3-positive elements (axons/fibers/terminals) within the amygdala, relative to
the distribution of neurons expressing the calcium-binding proteins, parvalbumin (PV),
calretinin (CR) and/or calbindin. Anterograde tracer injections into the NI revealed a
topographic distribution of NI efferents within the amygdala that was near identical to
the distribution of relaxin-3-immunoreactive fibers. Highest densities of anterogradely-
labeled elements and relaxin-3-immunoreactive fibers were observed in the medial
nucleus of the amygdala, medial divisions of the bed nucleus of the stria terminalis
(BST) and in the endopiriform nucleus. In contrast, sparse anterogradely-labeled and
relaxin-3-immunoreactive fibers were observed in other amygdala nuclei, including
the lateral, central and basal nuclei, while the nucleus accumbens lacked any
innervation. Using synaptophysin as a synaptic marker, we identified relaxin-3 positive
synaptic terminals in the medial amygdala, BST and endopiriform nucleus of amygdala.
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Our findings demonstrate the existence of topographic NI and relaxin-3-containing
projections to specific nuclei of the extended amygdala, consistent with a likely role for
this putative integrative arousal system in the regulation of amygdala-dependent social
and emotional behaviors.
Keywords: anxiety, arousal, emotion, motivation, neuropeptide, nucleus incertus, social behavior, theta rhythm
INTRODUCTION
The amygdala is considered a central node for processing
adaptive social and emotional behavior (Aggleton, 1993; Phelps,
2006; Adolphs, 2008). Sensory information arising from cerebral
cortex and thalamus enters the amygdala where information
acquires emotional value (LeDoux, 2000). In addition, amygdala
function extends beyond Pavlovian-like fear conditioning with
a role for amygdala processing described in valence (positive
and negative affective), reward, decision-making and recognition
of emotional facial expressions (Benarroch, 2015). In rodents,
olfactory information from the main and accessory olfactory
bulbs enters the amygdala where conspecific and allospecifics
are recognized and social interactions are evaluated (Scalia
and Winans, 1975; Ferguson et al., 2001; Pro-Sistiaga et al.,
2007; Trainor et al., 2010). Other telencephalic inputs to
the amygdala that originate in prefrontal cortex (McDonald,
1998; Vertes, 2004) and hippocampus (Canteras and Swanson,
1992) shape emotional processing by adding information to
past emotional experiences or the context in which emotional
experiences takes place (Sierra-Mercado et al., 2011). Intrinsic
connections between amygdala subnuclei convey information
to amygdala outputs (Pitkänen et al., 1997; Jolkkonen and
Pitkänen, 1998; Schmitt et al., 2012). These connections
are filtered/modulated by intrinsic GABAergic circuits (Sun
and Cassell, 1993) and most GABAergic neurons in the
amygdala contain the calcium-binding proteins, parvalbumin
(PV), calbindin (CB28kD) or calretinin (CR; McDonald and
Mascagni, 2001).
The amygdala is strongly innervated by projections arising
from a variety of monoamine neuron populations in the
brainstem. For example, serotoninergic afferents are dispersed
across multiple regions of the amygdala (Steinbusch, 1981;
Smith and Porrino, 2008; Bonn et al., 2013). Arousal and
stress induce an increase in serotonin concentrations in the
amygdala during fear conditioning (Kawahara et al., 1993;
Yokoyama et al., 2005; Mo et al., 2008; Christianson et al.,
2010) and serotonin transporter inhibitors (SSRIs) are used to
treat amygdala-related disorders, including anxiety, panic and
phobias (Sheehan et al., 1993; Gorman, 2003). SSRIs induce
increases in serotonin levels in amygdala (Bosker et al., 2001) and
increased expression of the serotonin transporter in the amygdala
reduces fear (Bocchio et al., 2015). This increased expression of
serotonin transporter results in reduction of fear and produces
impairment of recruitment of amygdala PV neurons (Bocchio
et al., 2015). In contrast, catecholaminergic afferents specifically
target the intercalated nuclei (Asan, 1998), which are important
for conveying information from the prefrontal cortex to the
central nucleus, subserving different aspects of processing
extinction memories (Quirk et al., 2003). Dopaminergic cells
of the lateral part of the ventral tegmental area and dorsal
edge of the substantia nigra pars compacta innervate the
amygdala, targeting mainly the intercalated nuclei (Loughlin
and Fallon, 1983; Asan, 1998), and dopamine D2 receptor
agonist infusion into the amygdala impairs the recall of fear
memories (Nader and LeDoux, 1999). In addition, noradrenergic
inputs to the amygdala contribute to the reconsolidation of fear
memories (Debiec and LeDoux, 2006; Chen and Sara, 2007), and
enhancement of noradrenergic transmission impairs extinction
of conditioned fear (Debiec et al., 2011). Furthermore, drugs
that modify monoaminergic signaling and metabolism have been
widely used for many years as treatments of psychiatric disorders,
such as anxiety, posttraumatic stress disorders, schizophrenia
and autism (e.g., Carlsson and Lindqvist, 1963; Creese et al.,
1976; Mailman and Murthy, 2010; Dinnissen et al., 2015).
Further in this regard, some studies have reported structural
changes in the amygdala in autistic patients. Children with
autism have larger amygdala volumes than controls, but during
adolescence, volumes become similar in both groups, which
indicates an abnormal program of early development of the
amygdala in autism (Schumann et al., 2004; Schumann and
Amaral, 2006).
The nucleus incertus (NI) in the pontine tegmentum is
another source of afferents to the main amygdala including
its extended part (Olucha-Bordonau et al., 2003). Projections
from the NI to telencephalic emotional processing centers run
in parallel with ascending monoamine pathways from the locus
coeruleus, raphe nuclei and the ventral tegmental area (Aston-
Jones et al., 1986; Vertes and Kocsis, 1994; Vertes et al., 1999)
and target similar areas including the septum, hippocampus,
amygdala and prefrontal cortex. The NI is primarily composed
of GABAergic neurons (Olucha-Bordonau et al., 2003; Ma et al.,
2007), including a population (∼30–50%) that expresses the
neuropeptide, relaxin-3 (Tanaka et al., 2005; Ma et al., 2007).
Relaxin-3 is the ancestral gene/peptide of the relaxin and insulin-
like peptide superfamily, and is highly conserved throughout
all vertebrate taxa (Wilkinson and Bathgate, 2007). The cognate
Gi/o-protein coupled receptor for relaxin-3 is relaxin family
peptide receptor-3, or RXFP3 (also known as GPCR135 and
SALPR (Liu et al., 2003; Boels et al., 2004), which is highly
expressed within medial and central nuclei of the rat amygdala
(Sutton et al., 2004; Ma et al., 2007). Experimental studies in
the rat and other species implicate the NI relaxin-3/RXFP3
system in the integrated regulation of arousal/vigilance, stress
responses, and associated homeostatic, emotional and cognitive
processes (Tanaka et al., 2005; Banerjee et al., 2010; Smith
et al., 2011, 2014; Ganella et al., 2013; Ma and Gundlach,
2015).
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Acquisition and retrieval of fear memories is reflected by
coherent hippocampal and amygdala neuronal activity at theta
frequency (4–12 Hz oscillations), also known as theta rhythm
(Lesting et al., 2011). Notably, the NI has been demonstrated
to modulate hippocampal theta rhythm (Nuñez et al., 2006;
Ma et al., 2009), and relaxin-3 neurons in the NI preferentially
fire in the early phase of theta oscillations (Ma et al., 2013). It
is well established that hippocampal theta rhythm is strongly
associated with arousal and exploration (O’Keefe, 1993) and
interactions between the hippocampus and the amygdala support
the contextual memory components of amygdala-dependent
fear conditioning (Sierra-Mercado et al., 2011). In this sense,
we have demonstrated that NI lesions result in impaired
extinction of conditioned fear (Pereira et al., 2013). Acquisition
of fear conditioning was not altered, but NI-lesioned rats
exhibited significantly delayed extinction and a stronger freezing
response, consistent with disruption of amygdala function and
its established regulation of the acquisition and extinction of fear
memories (Sierra-Mercado et al., 2011).
The relaxin-3/RXFP3 system has also been linked with
modulation of feeding and motivated behaviors. Acute and
chronic activation of RXFP3 increases food intake and weight
gain in rats (McGowan et al., 2006; Ganella et al., 2013), and
the effects of relaxin-3 on feeding behavior are dependent on
stress levels and are sex- and species-dependent (Lenglos et al.,
2013; Smith et al., 2014). In addition, rats fed with a high-fat
diet exhibit differential RXFP3 expression in the medial and
central nuclei of the amygdala (Lenglos et al., 2014). Disruption
of relaxin-3/RXFP3 signaling impairs motivated food seeking
and consumption in mice (Smith et al., 2014); and in an alcohol-
preferring (iP) rat strain, icv infusion of the RXFP3 antagonist,
R3(B1–22)R, or local infusion of R3(B1–22)R into the bed nucleus
of the stria terminalis (BST) attenuates stress-induced relapse
behavior (Ryan et al., 2013b).
Together, existing data suggest relaxin-3/RXFP3 signaling
modulates affective behavior and emotionality, and although
the existence of a relaxin-3 innervation of the rat amygdala
has been reported (Ma et al., 2007), details of the specific
innervation of the various nuclei and subnuclei have not been
described. Given the functionally distinct nature of the different
amygdala regions (Aggleton, 1993; Davis, 2000; Martínez-García
et al., 2012; Olucha-Bordonau et al., 2014), this study aimed to
examine the pattern of relaxin-3-immunoreactive afferent fibers,
in relation to the delineation of the amygdala nuclei provided
by the calcium-binding proteins, PV, CB-28kD and CR (Paxinos
et al., 2008).
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (300–400 g, n = 22) were used
in this study. All protocols were approved by the Animal
Ethics Committee of the Universitat de València (Spain). All
procedures were in line with directive 86/609/EEC of the
European Community on the protection of animals used for
experimental and other scientific purposes.
Anterograde Tracer Injections
Rats (n = 4) were anesthetized with a combination of ketamine
(55 mg/kg i.p., Imalgene, Merial Labs, Barcelona, Spain) and
xylacide (20 mg/kg i.p., xilagesic; Lab. Calier, Barcelona, Spain)
and trephine holes were drilled in the skull. Anterograde tracer
injections into the NI were made using 40 µm I.D. glass
micropipettes (coordinates from Bregma: AP −9.6 mm, ML
0 mm and DV 7.4 mm). For anterograde tracing, 15% miniruby
(mR, 10 kD biotinylated dextran amine (BDA) rhodamine-
labeled; Molecular Probes, Paisley, UK; n = 2, Figure 1A) or
biotinylated dextran amine (BDA, 10 kD; Molecular Probes,
Eugene, OR, USA; n = 2, Figure 1B) dissolved in 0.1 M phosphate
buffer (PB), pH 7.6 was iontophoretically delivered into the NI
by passing a positive current of 1 µA, 2 s on 2 s off through the
micropipette, over 10 min. The micropipette was left in place
for a further 10 min before withdrawal. After injections, the
surgical wound was sutured and rats were injected with Buprex
(0.05 mg/kg, i.p., Lab Esteve, Barcelona, Spain) for analgesia. Rats
were then allowed to recover for at least 7 days, prior to further
processing.
Brain Fixation and Sectioning
For analysis of tracing studies, IF and ICC, (n = 18)
rats were deeply anesthetized with Nembutal (150 mg/kg
i.p., Euthalender, Barcelona, Spain) and transcardially-perfused
with saline (250 ml) followed by fixative (∼500 ml of 4%
paraformaldehyde in 0.1 M PB, pH 7.4). Brains were dissected
and immersed in the same fixative for 4 h at 4◦C followed by
incubation in 30% sucrose in 0.01 M PBS pH 7.4 for 48 h at 4◦C.
Coronal sections (40 µm) were collected using a freezing slide
microtome (Leica SM2010R, Leica Microsystems, Heidelberg,
Germany). For each brain, six series of sections were obtained
and collected free-floating in 0.01 M PBS, and stored at−40◦C in
30% sucrose in 0.01 M PBS.
Immunohistochemistry for Relaxin-3 and
Calcium-Binding Proteins
For analysis of relaxin-3-immunoreactive fiber distribution in
relation to neurochemical/anatomical markers of amygdala
nuclei and subnuclei, double-label immunohistochemistry for
relaxin-3 and a number of different proteins was conducted.
The rabbit relaxin-3 antisera was produced at The Florey
Institute of Neuroscience and Mental Health (Parkville, VIC,
Australia) and has been characterized and widely used (Ma
et al., 2007; Smith et al., 2010; Olucha-Bordonau et al., 2012).
In cases where primary antibodies were raised in different host
species (rabbit and mouse), a combination of both antibodies
in a single primary antibody incubation was used. In cases
where primary antibodies were from the same host species,
sequential primary and secondary antibody incubations were
separated by overnight rinsing. For single primary antibody
incubations, sections were rinsed twice in Tris-buffered 0.05
M saline (TBS) pH 8.0 and transferred to blocking solution
(4% normal donkey serum (NDS), 2% bovine serum albumin
(BSA) and 0.2% Triton X100 in TBS) for 1 h at room
temperature. Sections were then transferred to primary antibody
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FIGURE 1 | Injection of an anterograde tracers, into the nucleus incertus (NI) and its transport to the amygdala. (A) Miniruby (mR) injection sites in the NI
of cases sf2 and sf3. (B) Biotinylated dextran amine (BDA) injection sites in the NI in cases fh11 and fh15). (C) Site of mR injection in the NI of case sf2. (D) A
darkfield image of the anterograde labeling in the ventromedial subnucleus of the lateral amygdala (LaVM) following a BDA injection into the NI (case fh11).
(E) A collage of darkfield images of anterogradely-labeled fibers in amygdala at a mid-caudal level. Dense NI projections were present in the intra-amygdala part of
the stria terminalis (STIA) and LaVM (case fh11). Calibration bars, 500 µm (A,B), 100 µm (C), 200 µm (D,E).
solution containing 1:2500 rabbit anti-relaxin-3 (Ma et al., 2007)
and either 1:5000 mouse anti-parvalbumin (PV27; Swant 235,
Swant, Bellinzona, Switzerland), 1:5000 mouse anti-calbindin-
D 28kD (CB38a; Swant), 1:2500 mouse anti-calretinin (CR 6B3;
Swant), in TBS containing 2% NDS, 2% BSA and 0.2% Triton
X100 for 48 h at 4◦C. Relaxin-3 and neuronal markers were
sequentially processed in secondary antibody and chromagen
visualization.
For relaxin-3, sections were rinsed twice in TBS and incubated
in 1:200 biotinylated donkey anti-rabbit antibody (711-065-152,
Jackson Immunoresearch, West Grove, PA, USA) for 2 h
at room temperature. Sections were then rinsed twice in
TBS and transferred to 1:100 Avidin-Biotin-Complex (ABC)
(Vectastain, Vector Laboratories, Burlingame, CA, USA). After
rinsing (2× TBS) the immunolabeling was revealed as a black
reaction product by immersing the sections in 0.025% 3,3′-
diaminobenzidine (DAB; Sigma, St Louis, MO, USA), 0.5%
ammonium nickel sulfate, 0.0024% H2O2 in Tris HCl, pH 8.0.
Sections were then rinsed for at least 2 h. Amygdala markers
were then revealed by incubation in appropriate biotinylated
secondary antibody (1:200 biotinylated donkey anti-mouse,
Jackson 715-065-150; or 1:200 biotinylated donkey anti-goat,
Jackson 705-065-147) for 2 h. Sections were then rinsed twice
in TBS and incubated in 1:100 ABC for 1 h. After rinsing
(2× TBS) the immunolabeling was revealed as a brown reaction
product by incubating the sections in 0.025% DAB 0.0024%
H2O2 in Tris HCl, pH 7.6. Following several rinses in 0.01 M PBS,
sections were mounted on chrom alum gelatin-coated slides, air-
dried, dehydrated with graded ethanol, cleared with xylene, and
coverslipped with DPX (Sigma).
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Immunofluorescence of Relaxin-3 and
Calcium-Binding Proteins
In studies of putative contacts between relaxin-3 fibers and
neuronal somata and processes positive for calcium binding
proteins, a mouse monoclonal relaxin-3 antibody was used
in combination with rabbit antisera against calcium binding
proteins. The monoclonal antibody against a recombinant
relaxin-3 immunogen has been used previously (Tanaka et al.,
2005; Ma et al., 2013) and the specificity of the antibody
has been demonstrated using brain sections from relaxin-
3 gene knockout mice (Watanabe et al., 2011). For double
immunofluorescence, sections were rinsed three times in PBS
0.01 M and transferred to blocking solution (4% normal goat
serum (NGS), 2% BSA and 0.1% Triton X100 in PBS) for
1 h at room temperature. Sections were then transferred to
primary antibody solution containing 1:5 mouse anti-relaxin-3
(cell culture media) and either 1:5000 rabbit anti-parvalbumin
(PV27; Swant 235, Swant), 1:10,000 rabbit anti-calbindin-D 28kD
(CB38a; Swant), 1:2000 rabbit anti-calretinin (CR 7697; Swant),
in PBS containing 2% NGS, 2% BSA and 0.1% Triton X100 for
48 h at 4◦C. Relaxin-3 and neuronal markers were sequentially
processed for the secondary antibody visualization steps. For
relaxin-3, sections were rinsed twice in PBS and incubated in
1:400 goat anti-mouse-Alexa488 antibody (115-545-146, Jackson
Immunoresearch) for 2 h at room temperature. Sections were
then rinsed three times in PBS and transferred to a new solution
for visualizing the calcium binding proteins. Thus, sections were
transferred to 1:400 goat anti-rabbit-Cy3 antibody (111-165-
003, Jackson Immunoresearch) for 2 h at room temperature.
Then sections were rinsed in PBS, mounted on clean slides and
coverslipped with FluoromountTM (F4680, Sigma).
Immunofluorescence of Relaxin-3 and
Synaptophysin
For double-label immunofluorescence, sections were rinsed
2 × 10 min and incubated in blocking media of TBS
containing 4% NDS, 2% BSA and 0.1% Triton X-100 for
1 h at room temperature. Sections were then incubated in
primary antibody solution containing 1:1250 rabbit anti-relaxin-
3 and 1:1000 mouse anti-synaptophysin (Sigma, S5768) in
TBS containing 2% NDS, 2% BSA and 0.2% Triton X100
for 48 h at 4◦C. Sections were then rinsed (3 × TBS)
and incubated in 1:200 Alexa488-conjugated donkey anti-
mouse (Jackson Immunoresearch, 715-545-150) and 1:200 Cy3-
conjugated donkey anti-rabbit (Jackson Immunoresearch, 711-
165-152). Sections were then briefly rinsed in 0.01 M PBS and
mounted on chrom alum gelatin-coated slides and coverslipped
with FluoromountTM (F4680, Sigma).
Quantification of colocalization of synaptophysin in relaxin-
3 fibers was conducted using sections double-reacted with
the monoclonal relaxin-3 antibody and rabbit synaptophysin
antisera (ab14692, Abcam, Cambridge, UK). Sections were
rinsed three times in PBS 0.01 M and transferred to blocking
solution (4% NGS, 2% BSA and 0.1% Triton X100 in PBS)
for 1 h at room temperature. Sections were then transferred to
primary antibody solution containing 1:5 mouse anti-relaxin-3
and 1:400 rabbit anti-synaptophysin. For relaxin-3 visualization,
sections were rinsed twice in PBS and incubated in 1:400
goat anti-mouse-Alexa488 antibody (Jackson Immunoresearch,
115-545-146) for 2 h at room temperature. For synaptophysin
visualization, sections were rinsed 3× PBS and transferred to a
solution containing 1:400 goat anti-rabbit-Cy3 antibody (Jackson
Immunoresearch, 111-165-003) for 2 h at room temperature.
Then sections were rinsed in PBS, mounted on clean slides and
coverslipped with FluoromountTM (F4680, Sigma).
Immunohistochemistry Analyses
DAB immunohistochemistry was examined and recorded
using a Nikon Eclipse E600 microscope equipped with
a DMX2000 digital camera (Nikon, Tokyo, Japan). Maps
of antigen distribution were constructed using a camera
lucida tube attached to a Zeiss Axioskop microscope (Zeiss,
Munich, Germany) at 20× magnification. These were scanned
and reduced to the final size for reproduction. Confocal
immunofluorescence was analyzed with a laser confocal scan
unit TCS-SP8 equipped with argon and helio-neon laser
beams attached to a DMIRB inverted microscope (Leica
Microsystems). For Cy3 fluorophore, excitation was 433 nm
for 560–618 nm emission. For Alexa 488, excitation was
488 nm for 510–570 nm emission. Serial 0.3 µm sections were
imaged to assess colocalization of relaxin-3-immunoreactive
terminals with synaptophysin, using Leica Confocal Software
(V 2.61).
In n = 3 cases, the co-localization of synaptophysin and
relaxin-3 was analyzed in different amygdala divisions. Captured
images using the 40× objective were taken through a total depth
of 10 µm and then reconstructed with the Leica application suite
(LAS-X) software. Firstly, we studied the percentage of relaxin-3
fibers that does not co-localize with synaptophysin. Second, we
studied the density of synaptophysin boutons along the length of
relaxin-3 fibers.
RESULTS
The delineation of the different amygdala nuclei has been
recently documented (Olucha-Bordonau et al., 2014; Paxinos and
Watson, 2014) and based on these topographical descriptions,
in this study we have considered three regions: the temporal
amygdala (TA), the bed nucleus of the stria terminalis
(ST1) which corresponded to the dorsal extension, and the
sublenticular extended amygdala (SLEA), which corresponded to
the ventral extension. These divisions are based on topography
to facilitate anatomical description, but do not correspond
to functional or ontogenetic divisions. Notably, the lateral,
basal and cortical nuclei are of pallial origin (Table 1), while
the two extensions, together with the medial and central
nuclei, constitute the medial and central extended amygdala,
1The bed nucleus of the stria terminalis has been classically abbreviated as
BST or BNST, however the different sub-subdivisions of this complex make
this unsuitable, thus following the 7th Edition of the Paxinos and Watson
Atlas of the Rat Brain, we have adopted the simplified abbreviation of ST to
refer to these nuclei.
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TABLE 1 | Distribution of anterogradely-labeled nucleus incertus (NI)
fibers and relaxin-3-positive fibers in pallial nuclei of amygdala.
Nucleus/area Anterogradely-labeled Relaxin-3
NI fibers IR
Cortical Lateropallial
pallial Nucleus of the lateral olfactory
tract (LOT)
− −
Bed nucleus of the accessory
olfactory tract (BAOT)
− −
Cortex amygdala transition
zone (CxA)
− −
Amygdalopiriform transition
area (APir)
− −
Dorsal endopiriform (DEn) +++ +++
Ventral endopiriform (VEn) +++ +++
Ventropallial
Anterior cortical amygdaloid
nucleus (ACo)
− −
Posterolateral cortical amygdaloid
nucleus (PLCo)
− −
Posteromedial cortical
amygdaloid nucleus (PMCo)
− −
Deep Lateropallial
pallial Basolateral (BL)
Basolateral anterior nucleus (BLA) + +
Basolateral posterior nucleus
(BLP)
++ ++
Basolateral ventral nucleus (BLV) + +
Basomedial
Basomedial anterior (BMA) +++ +++
Basomedial posterior (BMP) + +
Ventropallial
Lateral (La)
Lateral dorsolateral part (LaDL) + +
Lateral ventrolateral part (LaVL) ++ ++
Lateral medial part (LaM) ++ ++
Amygdalohippocampal transition
area
Posteromedial (AHiPM) ++++ ++++
Anterolateral (AHiAL) ++++ ++++
which are of sub-pallial origin (Table 2). We have used this
hierarchy to analyze the occurrence of anterograde tracing
and relaxin-3-immunoreactivity in different nuclei of the
amygdala.
Nucleus Incertus Projections to Amygdala
We successfully made BDA (n = 2) and mR (n = 2) tracer
injections that were restricted to the NI, with no spread of
tracer to the adjacent dorsal tegmental nucleus or pontine raphe
nucleus (Figures 1A–C). Anterogradely-labeled fibers in the
amygdala detected with both tracers were thin and varicose
(Figures 1D,E; data not shown), primarily occupying medial
aspects of the TA (Figures 1D,E, 2), and medial aspects of ST
and SLEA (Figures 3, 4).
Temporal Amygdala (TA)
Anterogradely-labeled fibers entering the amygdala complex
appeared to originate from fiber tracts within the medial
forebrain bundle and sublenticular area at rostral levels of the
TA (Figure 2A). The densest areas of NI innervation occupied
TABLE 2 | Distribution of anterogradely-labeled NI fibers and relaxin-3
positive fibers in subpallial nuclei of amygdala.
Nucleus/area Anterogradely- Relaxin-3
labeled NI fibers IR
Medial nucleus (Me)
Medial nucleus anterodorsal part (MeAD) ++++ +++
Medial nucleus anteroventral part (MeAV) ++++ +++
Medial nucleus posterodorsal part (MePD) + +
Medial nucleus posteroventral part (MePV) ++ ++
Central nucleus (Ce)
Central nucleus medial division (CeM) + +
Central nucleus lateral division (CeL) + +
Central nucleus capsular division (CeC) + +
Amygdalostriatal transition area (ASt) + +
Anterior amygdaloid area (AA) +++ +++
Intercalated nuclei (I) ++ ++
Bed nucleus of the stria terminalis (ST)
Intraamygdala part (STIA) +++ +++
Supracapsular part (STSC) + +
Medial anterior (STMA) +++ ++
Medial ventral (STMV) +++ ++
Lateral division (STL) − −
Lateral dorsal (STLD) − −
Lateral intermediate (STLI) − −
Lateral juxtacapsular (STLJ) + ++
Lateral posterior (STLP) − −
Fusiform nucleus (Fu) − −
Parastriatal nucleus (PS) − −
Bed nucleus of the anterior commissure (BAC) − −
Sublenticular extended amygdala (SLEA) + +
Sublenticular substantia innominata (SI) − −
Interstitial nucleus of the + +
posterior limb of the anterior
commissure (IPAC)
the medial amygdala nuclei and a broad band between the basal
lateral and cortical nuclei, which corresponded most closely
to the basomedial nuclei. Labeled fibers were observed within
the four nuclei of the medial amygdala—medial anterodorsal
(MeAD), medial anteroventral (MeAV), medial posterodorsal
(MePD) and medial posteroventral (MePV; Figures 2B,C).
However, in the MePD, the most medial region was devoid of
labeled fibers, which were concentrated in the lateral aspects of
this nucleus (Figure 2D). Most cortical amygdala nuclei were
devoid of labeled fibers except for the inner parts. In contrast,
a high density of fibers was observed in the anterior part of
the basomedial nucleus (BMA; Figures 2A–D), whereas the
posterior part (BMP) contained sparse anterograde labeling.
The intra-amygdala part of the ST (STIA) contained a high
density of labeled fibers (Figures 2B–D), with a differential
distribution observed within the lateral and basolateral nuclei,
along the rostrocaudal axis. While these nuclei contained
sparse labeling at anterior levels, fibers were more concentrated
at caudal levels, forming dense plexuses in the basolateral
posterior nucleus (BLP), lateral medial part (LaM) and lateral
ventrolateral part (LaVL) of the ventropallidal amygdala
(Figures 2E,F). At these caudal levels, a high density of
fibers was also observed in the anterolateral (AHiAL) and
posteromedial (AHiPM) parts of the amygdalohippocampal
transition area (Figure 2F). Sparse labeling was observed in
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FIGURE 2 | Distribution of anterograde fiber labeling in the temporal amygdala (TA) from a case with a BDA injection into the NI. Labeled fibers
occurred mainly in the medial aspects of the themporal amygdala and in a broad band in the basal nuclei. (A–F) Represents camera lucida drawings of the
corresponding bregma levels. Calibration bar 500 µm.
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the posteromedial cortical amygdala nucleus (PMCo), and the
amygdalopiriform transition area (APir) was devoid of any
innervation.
Anterogradely-labeled fibers (BDA and mR) were observed
crossing the basomedial nuclei to innervate lateral aspects of
the basolateral ventral nucleus (BLV) and the endopiriform
nuclei, giving rise to dense plexuses in both the DEn and ventral
endopiriform nuclei (VEn; Figures 2B–D, Table 1).
Nuclei of the Stria Terminalis (ST)
In the ST, anterogradely-labeled fibers were primarily observed
in the medial aspects at all rostrocaudal levels (Figures 3A–C).
At rostral and middle levels, fibers were observed in the anterior
(STMA) and ventral (STMV) nuclei of the medial nucleus of the
ST, encircling the anterior commissure bundles (Figures 3A,C),
and dispersed fibers were also observed in the lateral nuclei of
the ST. At caudal levels, labeled plexuses were observed in the
posterior medial (STMPM), posterior intermediate (STMPI) and
posterior lateral (STMPL) parts of the medial nucleus of the ST
(Figure 3C). No labeling was observed in any lateral nuclei at
these caudal levels.
Sublenticular Extended Amygdala
At anterior levels of the TA, a dense plexus of labeled fibers
was observed in the lateral preoptic area (LPO) and horizontal
limb of the diagonal band. In addition, some fibers ran
laterally to the anterior amygdala nuclei. Some fibers were
observed in the ventral (AAV) and dorsal (AAD) divisions of
the anterior amygdala nuclei, where fibers ran rostrally and
dorsally to innervate the sublenticular substantia innominata
(Figures 4A,B). Disperse fibers were also observed in the
basomedial nuclei of the amygdala and the interstitial nucleus
of the posterior horn of the anterior commissure (IPAC;
Figures 4A,B).
Distribution of Relaxin-3 Fibers within the
Amygdala
The distribution of relaxin-3-immunopositive fibers was similar
to that observed with anterograde-tracer labeling of NI inputs
to the amygdala. In order to identify the nature of target
neurons within the different amygdala nuclei, we used double-
label immunofluorescence for relaxin-3 and the calcium-
binding proteins, PV, calbindin-28kD (CB-28kD) and CR
(Figures 5, 6, 7).
Relaxin-3 Innervation of Temporal Amygdala (TA)
Six rostrocaudal levels of the amygdala, from −2.2 mm to
−3.6 mm relative to Bregma (Paxinos and Watson, 2014), were
assessed in these studies. In an effort to better describe the
distribution pattern observed, amygdala nuclei and subnuclei
were delineated using the distribution of PV, CB-28kD and CR
immunoreactivity. In general, PV-, CB-28kD and CR-positive
cells appeared dispersed in the amygdala areas derived from a
cortical-pallial origin, thus representing good landmarks for the
boundary between pallium and subpallium.
Strong PV labeling was present in the neuropil of the BLA
and BLP nuclei (data not shown), which clearly differentiates
FIGURE 3 | Distribution of anterograde fiber labeling in the bed nuclei
of the stria terminalis (ST) after a BDA injection into the NI. Labeled
fibers mainly occurred in the medial nuclei. (A–C) Represents the levels that
are shown in a camera lucida detail of the corresponding bregma levels.
Calibration bar 250 µm.
them from the La and the BMA/BMP. A dense concentration
of PV-positive neurons occurred in the CxA and in the
BLV (Figure 5A). PV cells were abundant in the PLCo
(Figures 5B–F). At some levels, PV-positive neurons appeared
at the boundary between the La and the BL nuclei (Figure 5E).
There were also abundant PV neurons in the AHi (Figure 5F),
whereas PV neurons were absent from the medial and central
nuclei.
CB-28kD-positive neurons followed a similar pattern, but
some CB-28kD neurons were also observed in amygdala areas
of subcortical-subpallial origin. This was especially evident in the
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FIGURE 4 | Distribution of anterograde fiber labeling in the
sublenticular extended amygdala (SLEA) after a BDA injection into the
NI. Labeled fibers mainly occurred in the medial aspects of the SLEA.
(A) Corresponds to Bregma −0–72.pdf (B) Corresponds to Bregma −0.84
mm. Calibration bar 250 µm.
MeAD and MeAV vs. MePD and MePV. Thus, the occurrence
of CB28kD-positive neurons is a specific feature of the anterior
nuclei of the medial amygdala (Figure 6A). At more caudal
levels, CB28kD neurons were concentrated in the cortical nuclei,
including the PLCo and the PMCo (Figures 6C–F).
CR immunoreactivity was present in an intense band in the
superficial layer of the cortical and medial amygdala nuclei.
CR-positive neurons were also present in the anterior nuclei
of the medial amygdala (MeAD and MeAV; Figures 7A–C),
but were scarce in the posterior nuclei (MePD and MePV).
Only dispersed CR-positive cells were observed in the BMP and
BMA (Figures 7B–E), while abundant CR-positive neurons were
present in the AHi and in the PMCo (Figure 7F). At these caudal
levels CR neurons were concentrated at the boundary between
the ventromedial subnucleus of the lateral amygdala (LaVM) and
BLP, an area that also contained dense plexuses of RLN3 fibers
(Figure 7F).
At the most rostral level, dense plexuses of varicose relaxin-
3-positive fibers were observed penetrating the MeAD and
MeAV of medial amygdala, originating from fiber tracts in
the nearby medial forebrain bundle (Figures 5A, 6A, 7A),
which then dispersed within more anterior levels giving
rise to dispersed labeling in the AD and AV nuclei and
extending to the SLEA. Sparse relaxin-3-positive fibers were
also observed innervating the intercalated nuclei surrounding
the lateral and basal nuclei, whereas the central nucleus was
devoid of immunoreactivity (Figures 5A–C, 6A–C, 7A–C).
Dense plexuses of relaxin-3 varicose fibers were observed
in DEn and VEn. A moderate relaxin-3 innervation was
also observed in a region between the cortical and the
basolateral amygdala that corresponded to the basomedial nuclei
(Figures 5A,B).
At progressively more caudal levels (Figures 5C,D, 6C,D,
7C,D), the densest relaxin-3 innervation was observed in the
anterodorsal (ADMeA) and anteroventral (AVMeA) medial
amygdala nuclei. Dense immunoreactivity was also observed
in the STIA (Figures 5D,E, 6D,E, 7D,E). Labeling was sparse
in the olfactory amygdala and piriform cortex, basal, lateral
and central amygdala, and dispersed fibers were observed
associated with intercalated cell groups lying between the
basolateral and basomedial amygdala nuclei.
At caudal levels, the relaxin-3 innervation was concentrated
in inner amygdala nuclei comprising the posteromedial cortical
area (PMCo), the AHi and the posterior basomedial nucleus
(BMP). A band of intense labeling was also observed at the
boundary between the lateral (LaVM) and posterior basolateral
nuclei BLP (Figures 5F, 6F, 7F).
Relaxin-3 Innervation of the Bed Nucleus of the Stria
Terminalis (ST)
ST nuclei were well delineated by CB-28kD and CR
immunoreactivity and relaxin-3 inputs were primarily confined
to the medial aspects of the ST (Figure 8). At the most
rostral levels of ST (Figures 8A,D), dense CB-28kD-positive
neurons were observed in the lateral nuclei comprising
the laterodorsal (STLD) and lateral juxtacapsular nuclei
(STLJ), which contained dispersed relaxin-3-positive fibers
(Figure 8A). In contrast, CR neurons were abundant in the
medial anterior nucleus (STMA), which contained moderate
levels of relaxin-3-positive fibers that coursed around the
anterior horn of the anterior commissure (Figure 8B).
Relaxin-3 inputs were also observed in nuclei adjacent to
the anterior commissure bundles, namely the ventral medial
nucleus (STMV), whilst the ventral aspects of the lateral
nucleus (STLV) contained sparse relaxin-3-positive fibers
(Figures 8A,B).
At mid-levels of the ST (Figures 8B,E), few relaxin-3-positive
fibers were observed in the medial regions, which comprised
both the anterior (STMA) and ventral (STMV) divisions that
were clearly identified by a dense cluster of CR-positive neurons
(Figure 8D). In contrast, dispersed fibers were observed in the
lateral nuclei (STLD, STLP and STLJ), and parastriatal (PS) and
funicular (Fu) nuclei.
At caudal levels (Figures 8C,F), relaxin-3-immunoreactive
fibers were concentrated in all medial nuclei, comprising the
posteromedial (STMPM), posterointermediate (STMPI) and
posterolateral (STMPL) divisions, and at this level, some relaxin-
3-positive fibers were also found in the posterior division of
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FIGURE 5 | Distribution of relaxin-3-positive fibers in the TA relative to the distribution of parvalbumin (PV)-positive neurons. Relaxin-3 fibers located in
the medial amygdala areas containing a lower proportion of PV neurons. (A–F) Camera lucida drawings of the corresponding Bregma levels. Calibration bar 250 µm.
the lateral nucleus (STLP). At caudal and ventral levels of the
ST, relaxin-3 fibers appeared to be in continuity ventrally with
labeled fibers coming from the rostral and dorsal aspects of the
SLEA (Figures 8C,F).
Relaxin-3 Innervation of the Bed Nucleus of the
Sublenticular Extended Amygdala (SLEA)
Relaxin-3-positive fibers were sparse in this rostral extension
of the amygdala. At the coronal level of the rostral amygdala,
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FIGURE 6 | Distribution of relaxin-3-positive fibers in the TA relative to the distribution of CB-28kD-positive neurons. Relaxin-3 fibers located in the
medial amygdala areas. (A–F) Camera lucida drawings of the corresponding Bregma levels. Calibration bar 250 µm.
relaxin-3-labeled fibers were most concentrated in the horizontal
diagonal band (HDB) and in the magnocellular preoptic nucleus
(MPO; Figures 9A,C). From this region, some fibers coursed
dorsally into the substantia innominata and laterally forming
a band in the anterior amygdala area located between the
ventral pallidum and the olfactory tubercle, which contained
CB-28kD-positive neurons (Figure 9A), but was devoid of
CR-positive cells (Figure 9C). Relaxin-3-labeled fibers were
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FIGURE 7 | Distribution of relaxin-3-positive fibers in the TA relative to the distribution of calretinin (CR)-positive neurons. Relaxin-3 fibers located in the
medial and caudal amygdala areas. (A–F) Camera lucida drawings of the corresponding Bregma levels. Calibration bar 250 µm.
also observed in the VEn and in the medial division of
the IPAC, whereas the ventral pallidum lacked relaxin-
3-immunoreactivity.
At more caudal levels of the SLEA (Figures 9B,D), a dense
plexus of relaxin-3-immunoreactive fibers was observed in the
LPO. These fibers extended laterally to the ventral (AAV) and
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FIGURE 8 | Distribution of relaxin-3-positive fibers in the nuclei of the ST relative to the distribution of CB-28kD-positive neurons (A,C,E) and
CR-positive neurons (B,D,F). Calibration bar 250 µm.
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FIGURE 9 | Distribution of relaxin-3-positive fibers in the SLEA relative to the distribution of CB28kD-positive neurons (A,C) and CR-positive
neurons (B,D). Calibration bar 250 µm.
dorsal (AAD) divisions of the anterior amygdala and dorsally
to the substantia innominata (Figures 9B,D). Sparse fibers were
also observed in the DEn and VEn. The interstitial nucleus of
the posterior arm of the anterior commissure contained two
divisions, the medial (IPACM) and the lateral (IPACL). While
the IPACM contained a dense plexus of relaxin-3 fibers, the
IPACL was devoid of fibers, but contained a population of CB-
28kD-positive neurons (Figures 9A–C). The ventral pallidum,
nucleus of the lateral olfactory tract (LOT) and the bed nucleus
of the accessory olfactory tract (BAOT) were devoid of relaxin-3
immunoreactivity (Figures 9B,D).
Distribution of mR-Positive NI and Relaxin-3-Positive
Inputs and Calcium-Binding Protein-Positive
Neurons in the Amygdala
Close appositions were observed between anterogradely-labeled
fibers positive for mR and PV soma and processes in the
ventrolateral division of the lateral amygdala (Figures 10A,B).
In permanent DAB stained samples, it was also possible
to find close contacts of mR positive fibers and CR
processes in the AHi (Figures 10C,D). Confocal images
from different amygdala nuclei revealed a graded pattern
of contacts between relaxin-3-positive fibers and calcium
binding protein somata and processes. These contacts were
evident in the La and BL divisions and in some cases the
contacts occurred between fibers and processes outside the
boundaries of the nucleus (Figures 10E–G). In the PLCo
relaxin-3 fibers were found surrounding the neuronal somata of
CB-28kD-positive neurons (Figures 11A–C). Also relaxin-
3 fibers contacted somata of CB-28kD neurons in the
lateral nucleus (Figures 11D–F). CR neurons of the medial
amygdala also received contacts from relaxin-3-positive fibers
(Figures 11G–I). Finally, contacts were also observed in the
medial nucleus of the ST where relaxin-3 fibers contacted
processes (Figures 11J–L).
Co-Localization of Relaxin-3 and
Synaptophysin
Synaptophysin (Syn) immunofluorescent staining was used to
confirm the presence of relaxin-3 synapses/terminations on
amygdala neurons. These studies resulted in granular labeling
surrounding neuronal soma, which appear as immuno-negative
‘‘dark holes’’. Syn boutons were clearly observed in the first
5–10 µm below the section surface and within this region Syn
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FIGURE 10 | Close apposition between mR anterogradely-labeled NI fibers or relaxin-3-positive fibers and PV-positive or CR-positive neurons.
(A) Posterior lateral amygdala region (containing mR-positive elements and neurons stained for PV (case sf2). (B) Higher magnification of the area labeled in (A)
representing a close contact between an anterogradely labeled fiber (black) and the soma of a PV-positive neuron. (C) Anterograde labeling was abundant in the
caudal aspects of the amygdala, particularly in the amygdalohippocampal transition area. (D) Some of the anterogradely-labeled elements contacted CR neuron
processes (arrow; case sf3). (E–G) Confocal images illustrating contacts between relaxin-3 fibers and PV dendrites in the basolateral ventral nucleus (BLV). The main
images represent the maximal projection and the insets a single 0.3 µm stack. Some dendrites of these neurons extend beyond the boundaries of the nucleus, in
this case in the ventral endopiriform nucleus (VEn) which contained dense relaxin-3 labeling. Calibration bars, 200 µm (A), 20 µm (B), 100 µm (C), 40 µm (D),
30 µm (E–G).
immunofluorescent boutons averaged 400 nm in diameter. Clear
colocalization of Syn with relaxin-3-immunoreactive boutons
was observed in the medial nucleus of the ST (Figures 12A–C),
DEn (Figures 12D–F), MeAD (Figures 12G–I) and MePV
(Figures 12J–L). In order to undertake a quantitative estimation
of the occurrence of double labeling (Syn/relaxin-3) in the
amygdala, tracks of fibers were measured and the number of
Syn boutons associated with the fiber was quantified (Table 3).
On average between 5–30% of relaxin-3 fibers did not contain
any Syn labeling. For the remaining relaxin-3 positive fibers, Syn
boutons occurred in 0.1–2 boutons per 10 µm of relaxin-3 fiber.
DISCUSSION
Using the anterograde tracers, mR and BDA, we observed a
NI projection to specific regions in the amygdala including the
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FIGURE 11 | Confocal images of close apposition between calcium binding positive neurons and processes and relaxin-3 positive fibers. Large
images correspond to a maximal projection of stacks of 20 images of scans of 0.3 µm. Insets illustrate a single 0.3 µm section illustrating the contact. (A–C) Contact
between a relaxin-3 fiber and a CB28kD somata in PLCo. (D–F) Contact of a relaxin-3 fiber with a CB28kD fiber in the La. (G–I) Contacts between RLN3 fibers and
CR positive somata and processes in the MeAD. (J–L) Contacts between RLN3 fibers and CR somata and processes in the STM. Calibration bar 20 µm.
nuclei of the ST and the SLEA. NI fibers extend throughout
the medial nuclei of the ST, medial aspects of the SLEA, and
in the TA extend throughout the medial amygdala. Dispersed
fibers were also located in a broad band along the basomedial
nuclei. This pattern agrees with the general distribution of
relaxin-3 fibers which are present within the medial ST and
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FIGURE 12 | Confocal images revealing the colocalization of relaxin-3 (red) and synaptophysin (green) in the framed areas of uppermost schematic
images. Single 0.5 µm sections displaying the localization (arrows) of relaxin-3 (A) synaptophysin (B) and a merged image (C) in the medial aspect of the ST. Single
0.5 µm sections displaying the localization (arrows) of relaxin-3 (D) synaptophysin (E) and a merged image (F) in the endopiriform nucleus. Single 0.5 µm section
displaying localization (arrows) of relaxin-3 (G) synaptophysin (H) and a merged image (I) in the medial amygdala (anterior dorsal nucleus). Single 0.5 µm section
displaying the localization (arrows) of relaxin-3 (J) synaptophysin (K) and a merged image (L) in the medial amygdala (posterior ventral nucleus). Calibration bars
5 µm.
SLEA, the medial amygdala, and in a broad band covering
the basomedial nuclei. In addition, groups of anterograde
and relaxin-3 fibers invaded specific centers like the caudal
VMLa. This suggests that a significant population of relaxin-3
fibers targeting the amygdala arise from the NI, although,
a contribution of relaxin-3 fibers from relaxin-3 producing
neurons in other areas, namely the pontine raphe nucleus,
ventral periaqueductal gray and/or the area dorsal to the lateral
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TABLE 3 | Quantitative estimation of the colocalization of synaptophysin
(syn) and relaxin-3 in the different nuclei of the amygdala.
Amygdala % of RLN3 fibers without Average number of Syn
nucleus colocalization with Syn boutons per 10 µm
botons mean ± SEM of RLN3 fiber ± SEM
SLEA 45.1 ± 3.1 0.61 ± 0.15
CeA 18.3 ± 2.3 1.05 ± 0.34
MeA 21.4 ± 9.0 1.97 ± 0.26
La 10.8 ± 2.4 4.94 ± 3.30
BL 29.2 ± 5.9 2.05 ± 0.62
BM 17.4 ± 7.0 2.16 ± 1.37
ST 27.8 ± 7.9 0.14 ± 0.32
Cortical 16.1 ± 8.6 2.04 ± 1.15
substantia nigra (Tanaka et al., 2005; Ma et al., 2007), cannot be
ruled out.
According to our data, there is a dense concentration of
relaxin-3 fibers in the medial amygdala which also contains a
high concentration of RXFP3 receptors. In contrast, the central
nucleus that also contains a high concentration of RXFP3
(Ma et al., 2007; Smith et al., 2010; Lenglos et al., 2014) is
largely devoid of relaxin-3. In the same way, while we have
observed a high concentration of relaxin-3 fibers in the medial
ST, RXFP3 receptors are concentrated in the lateral ST. Thus,
while in the medial amygdala, fibers and receptors occupy the
same location, there is a mismatch in the distributions in the
central nucleus and the nuclei of the ST. A mismatch between
fibers and the distribution of postsynaptic receptors has been
described for the amygdala opioid system (Agnati et al., 1986)
and volume transmission, whereby peptides can be delivered into
extrasynaptic spaces and diffuse for a long distance (Thureson-
Klein et al., 1986; Zhu et al., 1986) is a possible form of
neural communication in the amygdala. Although relaxin-3 is
present in synapses in the thalamus (Tanaka et al., 2005) and
in the medial septum (Olucha-Bordonau et al., 2012), a match-
mismatch between fibers and receptors has also been described
for the cholecystokinin (CCK) transmission system. CCK fibers
innervate the lateral central nucleus of the amygdala, which does
not display CCK2 receptors, and the intercalated nuclei, which
express CCK2 receptors, whereas the basolateral amygdala does
not contain fibers but is rich in CCK2 receptors (Pérez de la Mora
et al., 2007). CCK delivered in the central amygdala of rodents in
the absence of danger is thought to activate CCK2 receptors of
the basolateral amygdala and depolarize these neurons, leading
to a maintained basal level of arousal (Pérez de la Mora et al.,
2008). Thus, volume transmission is particularly adapted to
neuropeptide neurotransmission signaling (Pérez de la Mora
et al., 2007), as there are no peptide re-uptake mechanisms
and inactivation of peptides strongly depends on extracellular
peptidases, which limit their diffusion through the extracellular
space (Davis and Konings, 1993), as reported for substance P in
the spinal cord (Duggan et al., 1990, 1992). In this regard, relaxin-
3 can be slowly degraded by the insulin degrading enzyme
(Bennett et al., 2009) which is also expressed in the brain (Kuo
et al., 1993).
In addition to the medial extended amygdala, relaxin-3
and NI-anterogradely labeled fibers were observed in central
extended amygdala and in the lateral, basolateral and basomedial
nuclei. It is well documented that amongst the lateral basal and
central nuclei, sensory information is conveyed from the lateral
to the central nucleus (Pitkänen et al., 1997), a process important
for emotional processing and fear conditioning (Amorapanth
et al., 2000; Nader et al., 2001). In this regard, we have
demonstrated that electrolytic lesions of the NI impair within
session extinction of fear conditioning (Pereira et al., 2013).
Thus, putative relaxin-3 projections from the NI to the medial
and ventrolateral aspects of the lateral amygdala and to the
basolateral and basomedial nuclei could subserve a modulation of
the extinction process by activation of RXFP3 within these areas
and/or in the adjacent CeA.
Anatomical and functional comparisons reveal parallels
between the central relaxin-3 and neuropeptide S (NPS) systems.
NPS is expressed in neurons located in only a few brain
areas—including in the pericoerulear area, in the Kölliker-
Fuse nucleus, and in a small number of neurons within the
dorsomedial hypothalamic nucleus (Xu et al., 2004; Pape et al.,
2010; Clark et al., 2011), a similar distribution to that in humans
(Adori et al., 2015). A major target of the NPS system is
the endopiriform nucleus, which is also densely targeted by
relaxin-3 fibers. NPS infusion into the endopiriform nucleus
induced an increase in glutamatergic excitation assessed in ex
vivo preparations that, in turn, resulted in a general decrease
in GABAergic inhibition in the basal and lateral amygdala and
an enhancement of spike activity in these nuclei. In a parallel
fashion, infusion of NPS in this nucleus results in a reduction of
freezing in contextual but not cued fear conditioning (Meis et al.,
2008).
In the present studies, we have identified and detailed
direct inputs of NI and relaxin-3 fibers to neurons expressing
the calcium-binding proteins PV, CB-28kD and CR. Putative
contacts have been demonstrated in the lateral and basal
amygdala nuclei and were clearly evident at the border between
LaVM and BLP, in the CeA, and in the AHi transition area.
Specific types of inhibitory neurons characterized by their
expression of particular calcium-binding proteins, have been
shown to play a central role in fear processing (Ehrlich et al.,
2009). For example, PV neurons of the basolateral nucleus
differentially fire in association with an auditory cue or after
footshock, suggesting they constitute, along with amygdaloid
principal neurons, a dynamic disinhibitory microcircuit (Wolff
et al., 2014).
PV neurons are also known to inhibit principal neurons of
the lateral amygdala during noxious or salient stimuli (Chu
et al., 2012; Bienvenu et al., 2015). In the current study, contacts
between anterogradely-labeled NI fibers and PV neurons were
observed in the lateral amygdala, suggesting a possible action on
interneurons influencing the pathway from the lateral nucleus via
the basal nucleus and finally targeting the central nucleus, thus
providing a modulatory capability for altering fear acquisition
and extinction. We also observed that the intercalated nuclei
contain relaxin-3 fibers and these nuclei that surround the lateral
nucleus receive direct projections from the prefrontal cortex
which mediate the suppression of fear responses during the
extinction process (Quirk et al., 2003; Paré et al., 2004). Thus,
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NI relaxin-3 projections to the intercalated nuclei may contribute
to the modulation of the neural processes of fear extinction
(Pereira et al., 2013) and further investigations are warranted,
particularly in light of related functional impacts of relaxin-
3/RXFP3 signaling in related circuits.
In this respect, there is growing evidence that the NI plays
an important role in modulating arousal and cortical activation
via actions on the septohippocampal system and changes in
hippocampal theta rhythm (4–12 Hz oscillations detectable
in the EEG; Brown and McKenna, 2015; Orzeł-Gryglewska
et al., 2015). NI stimulation was initially demonstrated to
increase hippocampal theta power and in contrast, NI lesion
significantly attenuated hippocampal theta activity induced by
stimulation of the reticularis pontis oralis (Nuñez et al., 2006).
Similarly, increased hippocampal theta power was observed after
infusion of an RXFP3-specific agonist into the septum, and
infusion of an RXFP3-specific antagonist in the septum dose-
dependently attenuated hippocampal theta power and spatial
working memory in rats (Ma et al., 2009). Furthermore, we have
reported a differential effect of corticotrophin-releasing hormone
(CRH) on NI-relaxin-3 neurons in urethane-anesthetized rats,
whereby NI-relaxin-3 neurons exhibited spontaneous firing that
was phase-locked with hippocampal theta oscillations, whereas
non-relaxin-3 neurons did not (Ma et al., 2013). Similarly,
fear processing is related to changes in theta rhythm. During
retrieval of fear memories, the amygdala and hippocampus
display phase-locked activity at theta frequency (Paré et al., 2002;
Seidenbecher et al., 2003). More recently, unit recordings from
the infralimbic prefrontal cortex, the hippocampus CA1 and the
lateral amygdala revealed that the pattern of theta oscillations
correlated with individual behavioral responses during fear
acquisition, retrieval and extinction (Lesting et al., 2011, 2013).
Synchronization of theta oscillations between hippocampus and
amygdala could in part depend on a common projection from the
NI.
Central CRH infusion has been demonstrated to activate NI
neurons expressing CRH-R1 (Bittencourt and Sawchenko, 2000;
Van Pett et al., 2000), and stress activated neurons in the NI
express relaxin-3 (Tanaka et al., 2005; Banerjee et al., 2010).
Central infusion of an RXFP3 agonist has been found to have
anxiolytic effects in adult rats (Ryan et al., 2013a) and mice
(Zhang et al., 2015). Thus, these effects of RXFP3 signaling on
anxiety-related mechanisms may involve the amygdala, although
further studies are required in rat and mouse in appropriate
models to further assess this possibility.
In addition to the putative function of relaxin-3/RXFP3
signaling in stress mechanisms, another function attributed to
the NI relaxin-3 system is the modulation of feeding behavior.
Intra-hypothalamic or icv infusion of relaxin-3 or RXFP3-
selective agonists results in promotion of feeding in satiated
rats (McGowan et al., 2005, 2006; Haugaard-Kedström et al.,
2011; Shabanpoor et al., 2012) and some effects on feeding
behavior may occur via actions within the amygdala. Rats in
which obesity was induced with a high fat diet and refeeding after
food deprivation, displayed increased expression of RXFP3 in the
central amygdala, as well as in the paraventricular hypothalamic
nucleus, NI and nucleus of the olfactory tract, whereas such
changes were not observed in rats in which a high fat diet did
not induce obesity (Lenglos et al., 2014).
Finally, recent research has shown that central (icv)
administration of an RXFP3 antagonist produced a dose-related
decrease in self-administration of alcohol (Ryan et al., 2013b).
This effect is in part mediated by effects within the extended
amygdala, as bilateral infusion of an RXFP3 antagonist into the
bed nucleus of the ST decreased self-administration of alcohol
and stress-induced reinstatement of alcohol seeking (Ryan et al.,
2013b). Thus the NI/relaxin-3 innervation of the medial divisions
of the ST identified in the current study may provide the relaxin-
3 input involved.
In general, it appears that relaxin-3 positive fibers that can
potentially release the peptide are present in the medial division
of the amygdala and medial nuclei of the ST, while neurons which
express RXFP3 mRNA are present in these areas, but are more
concentrated in the central amygdala and the lateral nuclei of
the ST. Indeed a mismatch between areas expressing peptide
receptors and the location of fibers delivering peptide ligand
is also observed with the CRH innervation of the amygdala.
While the lateral central amygdala receives a dense innervation
of CRH fibers (Swanson et al., 1983; Sakanaka et al., 1986, 1987);
neurons expressing the CRH-R1 receptor are concentrated in
the medial nucleus of the central amygdala (Van Pett et al.,
2000). However, in transgenic mice expressing CRH-R1, the
dendritic tree of CRH-R1 neurons may be in close contact
with CRH fibers within surrounding areas (Justice et al., 2008).
Therefore, at this stage, it is possible that synaptic, extra-
synaptic or volume transmission mechanisms may be involved in
peptidergic transmission within the medial and lateral divisions
of the ST or within the medial and central nuclei of the
amygdala.
In conclusion, we have documented the topographical
projections from the NI to selective regions (nuclei/subnuclei) of
the amygdala, including the medial and extended amygdala, the
lateral and basal nuclei and the endopiriform nucleus, which may
modulate various amygdala-driven functions, including feeding,
social behavior, fear conditioning and extinction, and reward and
motivation. Separate or collateral projections of NI neurons to
the septum, hippocampus and amygdala may provide a neural
network capable of rhythmic theta synchronization between
the hippocampus and the amygdala during emotionally-related
processes. The presence of relaxin-3 in a relevant population
of these NI neurons and pharmacological studies with RXFP3-
selective peptides suggest that relaxin-3/RXFP3 signaling may
contribute to these important physiological and behavioral
modalities.
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